Sale!

SARS-CoV-2 Respiratory Comprehensive Panel Test Cost

Original price was: 5,460 د.إ.Current price is: 4,910 د.إ.

-10%

The SARS-CoV-2 Respiratory Comprehensive Panel Test, available at DNA Labs UAE for a cost of 4910 AED, is a sophisticated diagnostic tool designed to detect the presence of the SARS-CoV-2 virus, which is responsible for COVID-19, along with a wide range of other respiratory pathogens. This comprehensive panel test is particularly useful in scenarios where patients exhibit symptoms that could be attributed to various viral or bacterial infections, making it crucial for differential diagnosis.

By employing advanced molecular techniques, the test can simultaneously screen for multiple pathogens, ensuring a thorough assessment of the patient’s respiratory health. This is especially important during flu seasons or in the context of emerging infectious diseases, where symptoms overlap and accurate diagnosis can significantly impact treatment decisions and patient outcomes.

Conducted in the state-of-the-art facilities of DNA Labs UAE, this test offers a reliable, efficient, and comprehensive approach to respiratory pathogen detection, making it a valuable tool for clinicians in managing and controlling the spread of infections, including COVID-19. The cost of 4910 AED reflects the extensive range of pathogens screened by this panel and the sophisticated technology employed in the testing process.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SARS-COV-2 RESPIRATORY COMPREHENSIVE PANEL Test

Test Name: SARS-COV-2 RESPIRATORY COMPREHENSIVE PANEL Test

Components:

  • Sars-Cov-2 RT-PCR
  • CBC
  • NLR
  • CRP
  • H1N1 Qualitative RT PCR
  • Respiratory Comprehensive Panel

Price: 4910.0 AED

Sample Condition:

Submit Oropharyngeal and Nasopharyngeal Swabs inoculated in special viral transport medium (VTM) available from LPL. Ship refrigerated in a special transport box available from LPL. Duly filled Covid-19 Clinical Information Form (Form 44) / SRF ID as mandated by GOI is mandatory & Duly filled Swine Flu/H1N1 Clinical information form (Form 25) is mandatory AND 2 mL (0.5 mL min.) serum from 1 SST AND 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Overnight fasting is preferred.

Report Delivery: SampleMon / Wed / Fri by 9 am; Report Tue / Thu / Sat

Method: Real Time RT-PCR, Real Time PCR, Immunuturbidimetry, Electrical Impedence, VCS

Test Type: Infections

Doctor: Physician

Test Department:

Pre Test Information: Duly filled Covid-19 Clinical Information Form (Form 44) / SRF ID as mandated by GOI is mandatory & Duly filled Swine Flu/H1N1 Clinical information form (Form 25) is mandatory. Overnight fasting is preferred.

Test Details

The SARS-CoV-2 Respiratory Comprehensive Panel test is a diagnostic test used to detect the presence of the SARS-CoV-2 virus, which is responsible for causing COVID-19. This test is specifically designed to detect the virus in respiratory samples, such as nasal swabs or throat swabs.

The panel test typically includes multiple components, including:

  1. Nucleic Acid Amplification Test (NAAT): This test uses a technique called polymerase chain reaction (PCR) to amplify and detect specific genetic material (RNA) of the SARS-CoV-2 virus. It can identify the presence of the virus even at low levels.
  2. Gene Target Detection: The test targets specific genes of the SARS-CoV-2 virus, such as the N gene or the E gene, to confirm the presence of the virus. These genes are unique to the virus and are not found in other common respiratory viruses.
  3. Viral Load Quantification: Some panel tests also include a viral load quantification component, which measures the amount of viral genetic material present in the sample. This can help determine the severity of the infection and guide treatment decisions.
  4. Variant Detection: Some panel tests can also detect specific variants or mutations of the SARS-CoV-2 virus, such as the Delta variant or the Alpha variant. This information can be useful in tracking the spread of different variants and assessing their potential impact on public health.

The SARS-CoV-2 Respiratory Comprehensive Panel test is typically performed in a laboratory setting and requires specialized equipment and trained personnel. The results of the test can help healthcare providers diagnose COVID-19, monitor the progression of the infection, and guide appropriate treatment and isolation measures.

Test Name SARS-COV-2 RESPIRATORY COMPREHENSIVE PANEL Test
Components *Sars-Cov-2 RT-PCR*CBC*NLR*CRP*H1N1 Qualitative RT PCR *Respiratory Comprehensive Panel
Price 4910.0 AED
Sample Condition Submit Oropharyngeal and Nasopharyngeal Swabs inoculated in special viral transport medium (VTM) available from LPL. Ship refrigerated in a special transport box available from LPL. Duly filled Covid-19 Clinical Information Form (Form 44) \/ SRF ID as mandated by GOI is mandatory & Duly filled Swine Flu\/H1N1 Clinical information form (Form 25) is mandatory AND 2 mL (0.5 mL min.) serum from 1 SST AND 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Overnight fasting is preferred.
Report Delivery SampleMon / Wed / Fri by 9 am; Report Tue / Thu / Sat
Method Real Time RT-PCR, Real Time PCR, Immunuturbidimetry, Electrical Impedence, VCS
Test type Infections
Doctor Physician
Test Department:
Pre Test Information Duly filled Covid-19 Clinical Information Form (Form 44) / SRF ID as mandated by GOI is mandatory & Duly filled Swine Flu/H1N1 Clinical information form (Form 25) is mandatory. Overnight fasting is preferred.
Test Details

The SARS-CoV-2 Respiratory Comprehensive Panel test is a diagnostic test used to detect the presence of the SARS-CoV-2 virus, which is responsible for causing COVID-19. This test is specifically designed to detect the virus in respiratory samples, such as nasal swabs or throat swabs.

The panel test typically includes multiple components, including:

1. Nucleic Acid Amplification Test (NAAT): This test uses a technique called polymerase chain reaction (PCR) to amplify and detect specific genetic material (RNA) of the SARS-CoV-2 virus. It can identify the presence of the virus even at low levels.

2. Gene Target Detection: The test targets specific genes of the SARS-CoV-2 virus, such as the N gene or the E gene, to confirm the presence of the virus. These genes are unique to the virus and are not found in other common respiratory viruses.

3. Viral Load Quantification: Some panel tests also include a viral load quantification component, which measures the amount of viral genetic material present in the sample. This can help determine the severity of the infection and guide treatment decisions.

4. Variant Detection: Some panel tests can also detect specific variants or mutations of the SARS-CoV-2 virus, such as the Delta variant or the Alpha variant. This information can be useful in tracking the spread of different variants and assessing their potential impact on public health.

The SARS-CoV-2 Respiratory Comprehensive Panel test is typically performed in a laboratory setting and requires specialized equipment and trained personnel. The results of the test can help healthcare providers diagnose COVID-19, monitor the progression of the infection, and guide appropriate treatment and isolation measures.